Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

Journal of Clinical Oncology

Volumn 20, Issue 5, 2002, Pages 1304-1310

  Rouzier, Roman ^a   Extra, Jean Marc ^a   Klijanienko, Jerzy ^a   Falcou, Marie Christine ^a   Asselain, Bernard ^a   Vincent Salomon, Anne ^a   Vielh, Philippe ^a   Bourstyn, Edwige ^a  

^a Department of Surgery ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; THIOTEPA;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0036498789     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.5.1304     Document Type: Article

References (33)

1. Axillary lymph nodes and breast cancer
2. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
3. Treatment of breast cancer
4. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast
5. Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy
6. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
7. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy
8. Cytological diagnosis by fine needle sampling without aspiration
9. Histological grading and prognosis in breast cancer
10. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine needle samples of breast cancer: A prospective study including biochemical correlation and DNA flow cytometric analysis
11. Breast cancer proliferation measured on cytological samples: A study by flow cytometry of S-phase fractions and BrdU incorporation
12. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
13. ERBB2 overexpression in breast carcinomas: No positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy
14. Nonparametric estimation from incomplete observations
15. Statistical aspects of the analysis of data from retrospective studies of disease
16. Regression models and life tables
17. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer
18. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer
19. Stage III carcinoma of the breast: A detailed analysis
20. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
21. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma
22. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
23. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
24. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy
25. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
26. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
27. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
28. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
29. Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial
30. Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: A prospective randomized trial
31. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
32. Primary (neoadjuvant) chemotherapy and radiotherapy compared with radiotherapy alone in stage IIB-IIIA breast cancer
33. Frequency of first metastatic events in breast cancer: Implications for sequencing of systemic and local-regional treatment